U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774039) titled 'Early Cognitive Behavioral Therapy for Insomnia (CBT-I) in People Planning to Under Hematopoietic Stem Cell Transplant (HSCT)' on Aug. 11.

Brief Summary: This proposed study is a prospective, randomized, controlled Phase 1 clinical trial to determine feasibility, acceptability (Aim 1) and preliminary effect (Aim 2) to mitigate insomnia symptoms and fatigue and improve health-related quality of life in patients who are planning to undergo HSCT. The investigators plan to enroll n=30 with insomnia symptoms (Insomnia Severity Index >=10) who will be randomized into one of two groups: 1. A group that starts CBT-I after the initial evalua...